Abstract:In a study on the HLA‐DR antigens and phenotypes in a series of Dutch coeliac children and their first‐degree relatives, the B‐cell antigens of 36 unrelated coeliac children, 110 first‐degree relatives of 33 of them, and 201 controls were typed with the two‐colour fluorescence test. The most frequent antigen was HLA‐DR3 (69%), followed by DR7 (36%). The distribution of DR phenotypes showed that the most frequent was DR3/other DR (25%), followed by DR3/DR7 (17%), DR3/DR4 (14%), and DR3/DR3 (14%). However, due t… Show more
“…This latter haplotype is present in almost all the cases (except in 3) associated with DR7-DQ2 or DRB1*11 (serological DR5)-DQA1*0505-DQB1*0301 (35/185; 18.9%), although none of these last alleles, by themselves, present a statistically significant association with CD. This distribution of haplotypes has been previously reported in other Mediterranean countries such as Italy, France or Tunisia where a larger number of CD patients carry the DRB1*07-DQB1*0202-DQA1*0201 haplotype associated with DRB1*11-DQA1*0505-DQB1*0301, compared with North European populations that present a higher number of the DRB1*03-DQB1*0201-DQA1*0501 haplotype (25)(26)(27). Although isolated alleles have no statistical association with CD, haplotype DR4-DQ8 is found in 5.4% of patients (60% together with DQ2) and is the most frequent among the DQ2 negatives.…”
The association between human leukocyte antigen (HLA) class II antigens and celiac disease (CD) was analyzed in a Spanish population. No association with DRB1*04 and DQB1*0302 was noted. The main associated haplotype (70.8%) was DRB1*03-DQB1*0201-DQA1*0501(DR3-DQ2), followed by DRB1*07-DQB1*0202-DQA1*0201 (DR7-DQ2) haplotype, which is associated with DRB1*11-DQB1*0301-DQA1*0505 (DR11-DQ7). The combinations of DR3-DQ2 with DR7-DQ2, and DR7-DQ2 with DR11-DQ7, present a twofold risk compared with each haplotype in homozygosis. An independence test in DR3-DQ2 haplotype found that association with CD was attributable to the whole haplotype, but for DR7-DQ2 was secondary to DQB1/DQA1. There is no need of a double gene dosage to increase the risk. CD-associated alleles typing demonstrates a very high negative predictive value to exclude CD in risk groups.
“…This latter haplotype is present in almost all the cases (except in 3) associated with DR7-DQ2 or DRB1*11 (serological DR5)-DQA1*0505-DQB1*0301 (35/185; 18.9%), although none of these last alleles, by themselves, present a statistically significant association with CD. This distribution of haplotypes has been previously reported in other Mediterranean countries such as Italy, France or Tunisia where a larger number of CD patients carry the DRB1*07-DQB1*0202-DQA1*0201 haplotype associated with DRB1*11-DQA1*0505-DQB1*0301, compared with North European populations that present a higher number of the DRB1*03-DQB1*0201-DQA1*0501 haplotype (25)(26)(27). Although isolated alleles have no statistical association with CD, haplotype DR4-DQ8 is found in 5.4% of patients (60% together with DQ2) and is the most frequent among the DQ2 negatives.…”
The association between human leukocyte antigen (HLA) class II antigens and celiac disease (CD) was analyzed in a Spanish population. No association with DRB1*04 and DQB1*0302 was noted. The main associated haplotype (70.8%) was DRB1*03-DQB1*0201-DQA1*0501(DR3-DQ2), followed by DRB1*07-DQB1*0202-DQA1*0201 (DR7-DQ2) haplotype, which is associated with DRB1*11-DQB1*0301-DQA1*0505 (DR11-DQ7). The combinations of DR3-DQ2 with DR7-DQ2, and DR7-DQ2 with DR11-DQ7, present a twofold risk compared with each haplotype in homozygosis. An independence test in DR3-DQ2 haplotype found that association with CD was attributable to the whole haplotype, but for DR7-DQ2 was secondary to DQB1/DQA1. There is no need of a double gene dosage to increase the risk. CD-associated alleles typing demonstrates a very high negative predictive value to exclude CD in risk groups.
“…The strong relationship between HLA genetic factors and CD is illustrated by the impact of the HLA-DQ2 gene dose on the chance of disease development: HLA-DQ2 homozygous individuals have an at least five times higher risk of disease development compared with HLA-DQ2 heterozygous individuals [21,22]. In addition, the gene dosage is determined by the amount of expressed HLA-DQ2/DQ8 in the small intestine, caused by the combination of the ab chains of the DQ2 (A1*0501, B1*0201 or A1*0201, B1*0202) and DQ8 (A1*0301, B1*0302) heterodimers.…”
“…The 12th tube of the reaction identifies the DQB1*02 allele in homozygous, which is an important information, because studies reveal that homozygous haplotype, increases patient´s susceptibility to develop CD (17,21,22) .…”
Section: Determination Of Hla Dq2 and Dq8mentioning
-Background -Celiac disease is a permanent intolerance induced by gluten, which is expressed by T-cell mediated enteropathy, and has a high prevalence in the general population. There is evidence of a strong genetic predisposition to celiac disease. Objective -To determine the prevalence of genetic markers HLA-DQ2 and HLA-DQ8 in blood donors from São Paulo and measure human recombinant tissue transglutaminase antibody IgA class in HLA-DQ2 and HLA-DQ8 positive donors.Methods -A total of 404 blood donors from São Paulo city and Jundiaí were included in the study and signed the informed consent form. Information regarding diarrhea, constipation and abdominal pain in the last 3 months was collected. Determination of HLADQ2 and HLADQ8 alleles was performed in all participants and human recombinant tissue transglutaminase antibody class IgA was measured only in blood donors who presentedDQ2 and/or DQ8. Results -HLADQ2 and/or HLADQ8 were positive in 49% (198/404) of subjects. Positive samples were associated with alleles DR3, DR4, DR7, DR11 and DR12. The most frequent genotype was DR4-DQ8, which was present in 13.6% of samples, followed by genotypes DR3-DQ2 and DR7-DQ2 with DQB1*02 in heterozygous, which were present in 10.4% and 8.7%, respectively. Eleven out of 198 positive donors (5%) were positive to human tissue transglutaminase test. Conclusion -We observed a high prevalence of genetic markers for celiac disease, HLA-DQ2 and HLA-DQ8, in blood donors from São Paulo, similar to prevalence described in Europe. These findings show that the prevalence of celiac disease should not be rare in our country, but underdiagnosed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.